Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study

Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental Study

Survival rates of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) are inferior to those of pediatric ALL patients. In part, this may be caused by differences in treatment setting. Generally, children are treated in specialized pediatric hemato-oncology settings, whereas A...

Full description

Bibliographic Details
Main Authors: Margrietha van der Linde, Nikki van Leeuwen, Frank Eijkenaar, Anita W. Rijneveld, Rob Pieters, Henrike E. Karim-Kos
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cancers
Subjects:
ALL
specialized pediatric hemato-oncology care
site of treatment
AYAs
5-year survival
regression discontinuity
Online Access:https://www.mdpi.com/2072-6694/14/10/2451

Internet

https://www.mdpi.com/2072-6694/14/10/2451

Similar Items